Visualizza versione completa : etlt.ob + suwn.ob cinesi alla riscossa
Sue aziende molto interessanti ,ottmi i numeri,etlt piu pericolosa per via dei scandali societari con possibili truffe da parte della societa'.
suwn book value 0,14 net icome +278% eps 0,01 in questo quarter
Sunwin International Neutraceuticals Announces Financial Results of First Quarter of Fiscal Year 2006
Monday September 19, 4:05 pm ET
Net Income Surges 278 Percent
FORT LAUDERDALE, Fla., Sept. 19, 2005 (PRIMEZONE) -- Sunwin International Neutraceuticals, Inc. (OTC BB:SUWN.OB - News), an industry leader in the production and distribution of Chinese herbs, veterinary medicines and low calorie natural sweetener (Stevia) in China, today reported improved earning results for the first quarter of the fiscal year 2006 ending July 31, 2005. The Company recorded revenues of $3.17 million, a 4% decrease over the first quarter of fiscal year 2005 revenues of $3.299 million. Net income surged to $364,000 (EPS: $0.01 per share) in the current quarter of the fiscal year of 2006, an increase of 278% compared to net income of $96,000 in the first quarter of fiscal year 2005.
ADVERTISEMENT
The slight decrease in revenues was mainly caused by a temporary lull in Stevia production, as we are upgrading and relocating our Stevia manufacturing facilities. Management expects to commence full production of Stevia in September 2005. For more details about our financials, please review our 10Q filing of quarterly report filed with the United States Securities and Exchange Commission.
The Company ended the first quarter of the fiscal year of 2006 with $1.98 million in cash and cash equivalents, the strongest cash position in its history. Shareholder equity increased to $6.213 million or book value at $0.14 per share, its highest level ever.
Dongdong Lin, CEO of Sunwin, commented, ``We are very pleased with the financial performance for the first quarter. The results of the first quarter demonstrate our ability to continue to achieve revenue growth in core business revenues, while controlling expenses, improving profitability and strengthening the balance sheet. We expect to substantially increase our sales and profit margins in all of the three divisions in the coming quarters.''
Ms. Lin, concluded, ``The Company has made significant investments to upgrade its manufacturing facilities for three divisions. The upgraded manufacturing facilities will enhance our competitive advantage, thereby contributing to substantial growth in our sales and earnings. Meanwhile, we aggressively pursue our acquisition strategy to grow our core businesses. We expect to have a breakout year in the fiscal year of 2006.''
The Company recorded an impairment loss for the six month period ended June 30, 2004 of $53,517. There was no impairment loss recorded for the six month period ended June 30, 2005.
As a result of the foregoing, the Company had net income of $1,947,343 or $.06 per share for the six months ended June 30, 2005 compared to net income of $1,021,348 or $.03 per share for the corresponding period of the prior year.
Liquidity and Capital Resources
bene oggi suwn,le ho in carico da qualche settimana a 0,15
ottimo
bella, SI OK!
Bravo, Miracolo1 :clap:
bella, SI OK!
Bravo, Miracolo1 :clap:
potevo venderle a 0,3 e poi ricomprarle la volta passata :angry: :angry: :wall: :wall: comunque e' un buon titolo.
:yes: suwn.ob volumi a raffica oggi dopo la guidance ultra positiva :yes:
Sunwin International Neutraceuticals Sees Record Revenues and Earnings in the Fiscal Years of 2006 and 2007
Thursday November 10, 8:00 am ET
FORT LAUDERDALE, FL--(MARKET WIRE)--Nov 10, 2005 -- Sunwin International Neutraceuticals, Inc. (OTC BB:SUWN.OB - News), an industry leader in the production and distribution of Chinese herbs, veterinary medicines and low-calorie natural sweetener (Stevia) in China, today announced forecast for revenue and earnings for the fiscal years of 2006 and 2007, including its plans for the next 12 to 24 months in order to achieve substantial organic growth.
ADVERTISEMENT
"We made a commitment from the very onset of this process to keep the investment public up-to-date on our activities, and I see this as a prime opportunity to begin fulfilling this commitment," said Laiwang Zhang, Chairman and President of Sunwin International Neutraceuticals, Inc.
"We have been in business now since 1992. We anticipate substantial growth in the next three years, particularly because of global trends focusing on healthier life style. Revenues in 2005 were at $12.11 million with net income of $0.02 per share. On the basis of middle-year results, we expect to see a solid increase by the end of fiscal years of 2006 and 2007.
"We expect that our substantial growth will continue in the coming quarters and years. We have built up our Good Manufacturing Practice ("GMP") manufacturing facilities for both divisions of veterinary medicine and Chinese traditional medicine for future organic growth making us compliant with the current GMP standards required by the Chinese government. We estimate approximately one third of current Chinese manufacturers of veterinary medicine and Chinese Traditional Medicine will be able to comply with the strict requirement of GMP manufacturing facilities imposed by the Chinese government. The reduction of our competitors will provide us huge business opportunities that should allow us to increase our annual sales from approximately $6.54 million in annual sales of fiscal year 2005 of combined revenues of both divisions to $14 million to $20 million in the next 12 to 24 months. We expect to improve our net profit margin from 10% to 16%.
"With dramatically increasing demand for healthy food worldwide, our low-calorie natural sweetener (Stevia) leads the global trend for healthier eating and better life. Stevia is the only natural sweetener that has no calories, but provides the real sugar experience. A native to Paraguay, the Stevia plant boasts leaves that can be 30-times sweeter than sugar. Processed forms of pure Stevia can be 300 times sweeter than sugar. But the sweet surprise to this delectable little leaf lies in the fact that the human body does not metabolize the glycosides from the leaf or any of its processed forms. They pass right through the body and are eliminated without adding calories.
"The implications of this go far beyond the simple notion of being a weight watcher's dream. When Stevia products are in their pure unadulterated form they do not adversely affect blood glucose levels, which means that diabetics and hypoglycemics can use them as well. However, the glycosides are not the whole story. Studies have found that the leaf contains proteins, fiber, iron, phosphorus, calcium, potassium, sodium, magnesium, zinc, the flavonoid rutin, Vitamin A, Vitamin C and oil which contains 53 other nutritional constituents, making it the quintessential dietary supplement.
"In summary, our organic growth should allow us to achieve annual revenues of $25 to $30 million and earnings in a range of $0.06 to $0.08 per share in the next 12 to 24 months."
Mr. Zhang concluded, "Our Company continues to achieve record growth in our core business segments, while improving our profitability and strengthening our balance sheet. Management is very optimistic about our prospects, as demand continues to accelerate for Stevia worldwide. Sunwin has the financial backing, research expertise, and proven management team needed to execute on its growth plan. Overall, Sunwin should achieve record revenue and net profit growth for the full years of 2006 and 2007. This briefly sums up our activities at Sunwin, and we look forward to creating a momentum of continuous growth in value for years to come."
About Sunwin International Neutraceuticals, Inc.
Sunwin International Neutraceuticals, Inc. (OTC BB:SUWN.OB - News) is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, neutraceutical products, natural sweetener (Stevia), and veterinary medicines and feeds prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumer to provide a quality and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important innovative high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received award of Shandong Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more info about Sunwin, please visit http://www.sunwin.biz
Safe Harbor Statement
Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.
ma che succede? :eek: :eek: :confused: :mmmm:
Miracolo1,
Volevo condividere la mia analisi di SUWN:
POSITIVE ASPECTS:
1. The forecast (outlook) for FY 06 and FY 07 recently provided by the Chairman is excellent compared to prior years' growth (more than 100% growth in both revenue and earnings)
2. I believe this forecast is credible since it has been provided by the Chairman knowing 6 months of FY 06 actuals
3. a new manufacturing facility for the stevia products was completed last sept, and is now operative
4. a diversified product portfolio (natural sweeteners, herbal medicines and veterinary products), with herbal medicines that grew 320% last fiscal year.
5. an organic 0 calory sweeteneer has the potential to sell all over the world.
6. I believe the stock price doesn't reflect the new projected growth yet. Current market capitalization is only around $9Mil
7. Warrants issued by the company can be excercised at .15-.16 which is not far from the current price of .21, so I believe insiders will want to wait for a price around .3 or more before excercising them
8. CEO is female (...less of a chance of a scam IMO)
9. Distribution agreement to sell in the US could add additional sales.
10. revenue flow in the past has been consistent, easy to predict whithout much seasonality
11. SEC filings are very clear, detailed and easy to follow
RISKS:
1. Some of the key managers are very young (ex. CFO is 31)
2. The president owns another non public company that does transactions with suwn creating the possibility that some of the transactions could damage shareholders by gauging prices
3. company doesn't have much cash and will most likely have to issue more shares
4. For more risks like political risk, exchange rate risks etc. please read the SEC filings.
5. They don't have an independent board of directors yet
sono uscito da suwn perche stanno facendo una grossa dfiluizione
sono uscito da suwn perche stanno facendo una grossa dfiluizione
Continua a tenerla d'occhio comunque perche' la diluizione serve per finanziare il programma di acquisizioni in cina. hanno due acquisizioni che vogliono concludere entro breve e consentiranno di raddoppiare la capacita' produttiva.
Che online trader usi per comprare over the counter stocks? Io abito negli usa e uso ameritrade.
Dai messaggi che ho letto sei bravo a trovare aziende con ottimi potenziali.
Ciao e buona fortuna!
che testina averle vendute solo perche era un chinese e mi puzzava,mamma mia che succhiata di p.....e :eek: :eek:
miracolo- non ti preoccupare, succede a tutti di perdere occasioni. L'importante e' non perdere il prossimo treno ed essere piu' pazienti. Io ho guadagnato con suwn ma non tanto quanto avrei voluto. A me adesso piace molto ADY come long term play. Tengo la mia posizione e ne comprero' di piu' se si abbassa. Come shorter play mi piace molto NWD che dovrebbe supperare $2 a breve, e AOB dopo gli earnings dovrebbe volare verso $6. Cina e India sono i posti in cui puoi fare i $$$$. Il piano e' di guadagnare $$$ e comperare casa in california!! troppo freddo a philadelphia.
miracolo- non ti preoccupare, succede a tutti di perdere occasioni. L'importante e' non perdere il prossimo treno ed essere piu' pazienti. Io ho guadagnato con suwn ma non tanto quanto avrei voluto. A me adesso piace molto ADY come long term play. Tengo la mia posizione e ne comprero' di piu' se si abbassa. Come shorter play mi piace molto NWD che dovrebbe supperare $2 a breve, e AOB dopo gli earnings dovrebbe volare verso $6. Cina e India sono i posti in cui puoi fare i $$$$. Il piano e' di guadagnare $$$ e comperare casa in california!! troppo freddo a philadelphia.
ho fatto un 40% mi sembra quando le ho vendute,meglio di niente ;( ady la conosco la seguivo ancora quando stava sui 7 ma mai presa.
Per ora i chinesi li evito punto su altri titoli tmg,sim,ksww.ob,ltfd.ob,job,ezm,cnu
SOno appena uscito da aey con +100% quindi ogni tanto un buon treno lo prendo :D
Grazie per la lista delle aziende che ti piacciono. ksww.ob mi piace molto.
Grazie per la lista delle aziende che ti piacciono. ksww.ob mi piace molto.
ksww.ob a 2 era una affare grande come una casa,nessuno mi ha ca ga to cavli loro.Se danno un atra trimestrale buona e passano alla amex la vendo oltre i 10
oggi ho comperato sim,ksww.ob,ltfd.ob,ezm. ksww e ltfd mi sembrano ancora sottovalutate. grazie per il consiglio, penso che in un paio di mesi dovremo vederle molto piu' in alto.
Le cinesi oggi erano in fuoco AOB, CMED, SUWN and BBC in particolare. Ripeto che c'e' molto molto interesse in questo momento in Cina e India.
oggi ho comperato sim,ksww.ob,ltfd.ob,ezm. ksww e ltfd mi sembrano ancora sottovalutate. grazie per il consiglio, penso che in un paio di mesi dovremo vederle molto piu' in alto.
Le cinesi oggi erano in fuoco AOB, CMED, SUWN and BBC in particolare. Ripeto che c'e' molto molto interesse in questo momento in Cina e India.
sei pazzo che comperi tutto il mio portafoglio? :eek: :D Mi ero dimenticato che ho anche gv ,vedi se ti piace :o
aggiornamento suwn.ob :eek: :eek:
mamma mia che roba 1200% dalla mia segnalazione :eek:
vBulletin® v3.7.2, Copyright ©2000-2009, Jelsoft Enterprises Ltd.